微创机器人-B(02252)今日盘中大涨5.05%,引发了市场的广泛关注。
公司近期发布业务更新公告,显示旗下腔镜、骨科、血管介入核心产品的综合订单量已累计超过100台,其中图迈腔镜手术机器人全球订单达39台,商业化装机突破30台。公司骨科手术机器人鸿鹄全球订单也达到25台,累计订单超过40台。
订单数据超出市场预期,说明微创机器人产品近年获批后商业化进程加快,市场需求旺盛。分析人士认为,订单量的大幅增长,将催化公司未来营收和利润释放,增强了市场对于公司长期增长前景的信心,故推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.